MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Moderna, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026
$226.89+8.88 (+4.07%)
Close on Oct 19, 2026
- Market cap
- $90.30B
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
79.9%
319M of 399M shares
Institutional holders
781
147 new, 83 sold out
Net institutional buying
11M
In Q2 2026
Insider trades, 12 months
0 buys · 19 sales
Net sold $64.63M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| FMR LLC | 51,803,891 | 13.10% | 13G (passive) amendment | Jun 30, 2026 |
| Abigail P. Johnson | 41,301,469 | 10.60% | 13G (passive) amendment | Jan 30, 2026 |
| Stéphane Bancel | 30,384,866 | 7.80% | 13G (passive) amendment | Dec 31, 2023 |
| Vanguard Capital Management | 25,933,824 | 6.53% | 13G (passive) | Mar 31, 2026 |
| BlackRock, Inc. | 25,301,057 | 6.60% | 13G (passive) amendment | Dec 31, 2023 |
| Capital World Investors | 22,276,996 | 5.60% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of MRNA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| FMR LLC | 51,859,891 | 12.99% | $3.63B | +6,187,867 | 0.16% |
| BlackRock, Inc. | 30,599,409 | 7.66% | $2.14B | +963,533 | 0.03% |
| Vanguard Capital Management LLC | 23,208,792 | 5.81% | $1.63B | +336,334 | 0.03% |
| Capital World Investors | 22,276,996 | 5.58% | $1.56B | +3,579,302 | 0.18% |
| Baillie Gifford & Co | 18,206,778 | 4.56% | $1.28B | −1,779,098 | 1.16% |
| State Street Corp | 15,726,193 | 3.94% | $1.10B | +864,784 | 0.03% |
| Vanguard Portfolio Management LLC | 15,581,313 | 3.90% | $1.09B | −35,054 | 0.05% |
| Geode Capital Management, LLC | 9,710,335 | 2.43% | $678.82M | +275,203 | 0.04% |
| Morgan Stanley | 9,538,094 | 2.39% | $667.95M | +1,066,831 | 0.04% |
| Theleme Partners LLP | 8,057,571 | 2.02% | $564.27M | +9,326 | 33.52% |
| Two Sigma Investments, LP | 7,193,530 | 1.80% | $503.76M | −1,892,874 | 0.36% |
| Invesco Ltd. | 5,780,299 | 1.45% | $404.79M | +995,541 | 0.03% |
| Price T Rowe Associates Inc /Md/ | 5,589,560 | 1.40% | $391.44K | +4,850,982 | 0.04% |
| Charles Schwab Investment Management Inc | 4,838,884 | 1.21% | $338.87M | +104,528 | 0.05% |
| Goldman Sachs Group Inc | 4,671,950 | 1.17% | $327.18M | −1,931,747 | 0.03% |
| Flagship Pioneering Inc. | 4,632,149 | 1.16% | $324.39M | – | 21.07% |
| UBS Group AG | 4,463,211 | 1.12% | $312.56M | +55,304 | 0.04% |
| Bnp Paribas Arbitrage, Snc | 4,377,120 | 1.10% | $306.53M | +59,901 | 0.11% |
| Norges Bank | 3,026,074 | 0.76% | $211.92M | New | 0.02% |
| Northern Trust Corp | 2,985,329 | 0.75% | $209.06M | +33,288 | 0.02% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 781 | 319M | 79.9% | 147 / 260 | 238 / 83 | 32M | 21M |
| Q1 2026 | 726 | 308M | 77.2% | 148 / 239 | 201 / 84 | 85M | 40M |
| Q4 2025 | 674 | 305M | 76.4% | 112 / 169 | 254 / 69 | 54M | 26M |
| Q3 2025 | 644 | 277M | 69.4% | 68 / 204 | 228 / 90 | 21M | 39M |
| Q2 2025 | 675 | 295M | 73.9% | 92 / 235 | 218 / 104 | 40M | 26M |
| Q1 2025 | 695 | 282M | 70.7% | 88 / 260 | 210 / 127 | 39M | 33M |
| Q4 2024 | 746 | 277M | 69.4% | 145 / 234 | 251 / 170 | 37M | 23M |
| Q3 2024 | 790 | 264M | 66.0% | 63 / 258 | 325 / 218 | 44M | 19M |
| Q2 2024 | 955 | 264M | 66.1% | 128 / 334 | 306 / 64 | 18M | 29M |
| Q1 2024 | 901 | 276M | 69.1% | 111 / 328 | 297 / 82 | 30M | 19M |
| Q4 2023 | 885 | 265M | 66.3% | 141 / 272 | 337 / 134 | 29M | 11M |
| Q3 2023 | 891 | 247M | 61.9% | 82 / 353 | 307 / 143 | 16M | 16M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of MRNA | Value | % of fund | As of |
|---|---|---|---|---|---|
| Growth Fund of America | 14,500,000 | 3.63% | $684.26M | 0.19% | May 31, 2026 |
| Vanguard Total Stock Market Index Fund | 11,331,692 | 2.84% | $793.56M | 0.03% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 9,154,510 | 2.29% | $641.09M | 0.04% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 8,190,072 | 2.05% | $573.55M | 0.30% | Jun 30, 2026 |
| Fidelity Growth Company Fund | 6,205,997 | 1.55% | $292.86M | 0.30% | May 31, 2026 |
| Fidelity OTC Portfolio | 5,313,300 | 1.33% | $291.28M | 0.68% | Jul 31, 2026 |
| Vanguard Small-Cap Value Index Fund | 5,187,970 | 1.30% | $363.31M | 0.54% | Jun 30, 2026 |
| iShares Core S&P 500 ETF | 4,857,193 | 1.22% | $340.15M | 0.04% | Jun 30, 2026 |
| Growth Fund | 4,620,700 | 1.16% | $323.59M | 0.57% | Jun 30, 2026 |
| Vanguard International Growth Fund | 4,584,709 | 1.15% | $216.35M | 0.49% | May 31, 2026 |
| Fidelity 500 Index Fund | 4,450,208 | 1.11% | $210.01M | 0.03% | May 31, 2026 |
| Fidelity Contrafund | 4,335,983 | 1.09% | $303.65M | 0.17% | Jun 30, 2026 |
| Invesco S&P 500 Equal Weight ETF | 4,051,567 | 1.01% | $222.11M | 0.23% | Jul 31, 2026 |
| iShares Biotechnology ETF | 2,574,707 | 0.64% | $180.31M | 1.98% | Jun 30, 2026 |
| Vanguard U.S. Growth Fund | 2,550,076 | 0.64% | $120.34M | 0.25% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Stephane Bancel | Chief Executive Officer, Director | 13,005,140 | 3.26% | Aug 7, 2026 |
| Stephen Hoge | President | 1,758,359 | 0.44% | Sep 16, 2026 |
| James M. Mock | Chief Financial Officer | 74,375 | 0.02% | Sep 14, 2026 |
| Shannon Thyme Klinger | Chief Legal Officer | 87,044 | 0.02% | Sep 8, 2026 |
| Soria Ester Banque | Chief Commercial Officer | – | – | Jul 7, 2026 |
| Michael R. McDonnell | Director | – | – | Jul 10, 2026 |
| Noubar Afeyan | Director | 6,856,164 | 1.72% | May 22, 2026 |
| Abbas Hussain | Director | 12,066 | 0.00% | May 8, 2026 |
| David M. Rubenstein | Director | 9,643 | 0.00% | May 8, 2026 |
| Elizabeth E. Tallett | Director | 4,761 | 0.00% | May 8, 2026 |
| Elizabeth G. Nabel | Director | 19,317 | 0.00% | May 8, 2026 |
| Francois Nader | Director | 32,781 | 0.01% | May 8, 2026 |
| Sandra Horning | Director | 18,585 | 0.00% | May 8, 2026 |
| Paul Sagan | Director | 494,133 | 0.12% | May 1, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Stephen Hoge President | Sep 15, 2026 | Option exercise | +76,452 | $12.21 | $933.48K | 1,602,310 |
| Stephen Hoge President | Sep 15, 2026 | Sale(10b5-1 plan) | −40,281 | $146.07 | $5.88M | 1,562,029 |
| Stephen Hoge President | Sep 14, 2026 | Option exercise | +76,453 | $12.21 | $933.49K | 1,566,152 |
| Stephen Hoge President | Sep 14, 2026 | Sale(10b5-1 plan) | −40,294 | $144.13 | $5.81M | 1,525,858 |
| James M. Mock Chief Financial Officer | Sep 10, 2026 | Sale(10b5-1 plan) | −19,836 | $134.49 | $2.67M | 74,375 |
| James M. Mock Chief Financial Officer | Sep 10, 2026 | Sale(10b5-1 plan) | −15,000 | $134.49 | $2.02M | 59,375 |
| James M. Mock Chief Financial Officer | Sep 10, 2026 | Option exercise | +19,836 | $30.96 | $614.12K | 94,211 |
| Shannon Thyme Klinger Chief Legal Officer | Sep 4, 2026 | Option exercise | +11,797 | – | – | 87,044 |
| Shannon Thyme Klinger Chief Legal Officer | Sep 4, 2026 | Tax withholding | −5,704 | $148.87 | $849.15K | 81,340 |
| James M. Mock Chief Financial Officer | Sep 4, 2026 | Tax withholding | −5,704 | $148.87 | $849.15K | 74,375 |
| James M. Mock Chief Financial Officer | Sep 4, 2026 | Option exercise | +11,797 | – | – | 80,079 |
| Shannon Thyme Klinger Chief Legal Officer | Sep 1, 2026 | Sale(10b5-1 plan) | −3,471 | $139.95 | $485.77K | 74,129 |
| Shannon Thyme Klinger Chief Legal Officer | Sep 1, 2026 | Option exercise | +3,471 | $30.96 | $107.46K | 77,600 |
| Shannon Thyme Klinger Chief Legal Officer | Sep 1, 2026 | Tax withholding | −1,048 | $140.34 | $147.08K | 75,247 |
| Shannon Thyme Klinger Chief Legal Officer | Sep 1, 2026 | Option exercise | +2,166 | – | – | 76,295 |
| James M. Mock Chief Financial Officer | Sep 1, 2026 | Tax withholding | −1,197 | $140.34 | $167.99K | 68,282 |
| James M. Mock Chief Financial Officer | Sep 1, 2026 | Option exercise | +2,475 | – | – | 69,479 |
| Stephen Hoge President | Sep 1, 2026 | Tax withholding | −4,489 | $140.34 | $629.99K | 1,489,699 |
| Stephen Hoge President | Sep 1, 2026 | Option exercise | +9,283 | – | – | 1,494,188 |
| Shannon Thyme Klinger Chief Legal Officer | Aug 28, 2026 | Option exercise | +329 | – | – | 74,289 |
| Shannon Thyme Klinger Chief Legal Officer | Aug 28, 2026 | Tax withholding | −160 | $142.77 | $22.84K | 74,129 |
| James M. Mock Chief Financial Officer | Aug 28, 2026 | Option exercise | +329 | – | – | 67,164 |
| James M. Mock Chief Financial Officer | Aug 28, 2026 | Tax withholding | −160 | $142.77 | $22.84K | 67,004 |
| Stephen Hoge President | Aug 28, 2026 | Tax withholding | −296 | $142.77 | $42.26K | 1,484,905 |
| Stephen Hoge President | Aug 28, 2026 | Option exercise | +611 | – | – | 1,485,201 |
| Shannon Thyme Klinger Chief Legal Officer | Aug 27, 2026 | Option exercise | +774 | – | – | 74,335 |
| Shannon Thyme Klinger Chief Legal Officer | Aug 27, 2026 | Tax withholding | −375 | $149.66 | $56.12K | 73,960 |
| James M. Mock Chief Financial Officer | Aug 27, 2026 | Option exercise | +774 | – | – | 67,210 |
| James M. Mock Chief Financial Officer | Aug 27, 2026 | Tax withholding | −375 | $149.66 | $56.12K | 66,835 |
| Stephen Hoge President | Aug 27, 2026 | Tax withholding | −695 | $149.66 | $104.01K | 1,484,590 |
| Stephen Hoge President | Aug 27, 2026 | Option exercise | +1,437 | – | – | 1,485,285 |
| Stephane Bancel Chief Executive Officer, Director | Aug 6, 2026 | Option exercise | +252,469 | $19.15 | $4.83M | 6,440,260 |
| Stephane Bancel Chief Executive Officer, Director | Aug 5, 2026 | Sale(10b5-1 plan) | −39,891 | $58.12 | $2.32M | 6,374,835 |
| Stephane Bancel Chief Executive Officer, Director | Aug 5, 2026 | Option exercise | +499,246 | $19.15 | $9.56M | 6,687,037 |
| Stephane Bancel Chief Executive Officer, Director | Aug 5, 2026 | Sale(10b5-1 plan) | −147,473 | $56.21 | $8.29M | 6,539,564 |
| Stephane Bancel Chief Executive Officer, Director | Aug 5, 2026 | Sale(10b5-1 plan) | −187,044 | $58.79 | $11.00M | 6,187,791 |
| Stephane Bancel Chief Executive Officer, Director | Aug 5, 2026 | Sale(10b5-1 plan) | −124,838 | $56.96 | $7.11M | 6,414,726 |
| Stephen Hoge President | Jul 15, 2026 | Option exercise | +16,110 | $19.15 | $308.51K | 1,537,184 |
| Stephen Hoge President | Jul 15, 2026 | Sale(10b5-1 plan) | −53,336 | $67.60 | $3.61M | 1,483,848 |
| Stephen Hoge President | Jul 15, 2026 | Option exercise | +37,226 | $19.15 | $712.88K | 1,521,074 |
| James M. Mock Chief Financial Officer | Jul 2, 2026 | Tax withholding | −703 | $72.50 | $50.97K | 66,436 |
| James M. Mock Chief Financial Officer | Jul 2, 2026 | Option exercise | +1,452 | – | – | 67,139 |
| Stephen Hoge President | Jun 15, 2026 | Sale(10b5-1 plan) | −53,336 | $51.37 | $2.74M | 1,483,848 |
| Stephen Hoge President | Jun 15, 2026 | Option exercise | +37,226 | $19.15 | $712.88K | 1,521,074 |
| Stephen Hoge President | Jun 15, 2026 | Option exercise | +16,110 | $19.15 | $308.51K | 1,537,184 |
| James M. Mock Chief Financial Officer | Jun 5, 2026 | Option exercise | +11,798 | – | – | 71,392 |
| James M. Mock Chief Financial Officer | Jun 5, 2026 | Tax withholding | −5,705 | $51.59 | $294.32K | 65,687 |
| Shannon Thyme Klinger Chief Legal Officer | Jun 5, 2026 | Option exercise | +11,798 | – | – | 79,266 |
| Shannon Thyme Klinger Chief Legal Officer | Jun 5, 2026 | Tax withholding | −5,705 | $51.59 | $294.32K | 73,561 |
| Shannon Thyme Klinger Chief Legal Officer | Jun 4, 2026 | Option exercise | +3,471 | $30.96 | $107.46K | 70,939 |
| Shannon Thyme Klinger Chief Legal Officer | Jun 4, 2026 | Sale(10b5-1 plan) | −3,471 | $50.00 | $173.55K | 67,468 |
| Shannon Thyme Klinger Chief Legal Officer | Jun 1, 2026 | Tax withholding | −1,047 | $47.19 | $49.41K | 67,468 |
| Shannon Thyme Klinger Chief Legal Officer | Jun 1, 2026 | Option exercise | +2,165 | – | – | 68,515 |
| Stephen Hoge President | Jun 1, 2026 | Option exercise | +9,282 | – | – | 1,488,336 |
| Stephen Hoge President | Jun 1, 2026 | Tax withholding | −4,488 | $47.19 | $211.79K | 1,483,848 |
| James M. Mock Chief Financial Officer | Jun 1, 2026 | Tax withholding | −1,197 | $47.19 | $56.49K | 59,594 |
| James M. Mock Chief Financial Officer | Jun 1, 2026 | Option exercise | +2,475 | – | – | 60,791 |
| James M. Mock Chief Financial Officer | May 28, 2026 | Option exercise | +328 | – | – | 58,475 |
| James M. Mock Chief Financial Officer | May 28, 2026 | Tax withholding | −159 | $47.61 | $7.57K | 58,316 |
| Shannon Thyme Klinger Chief Legal Officer | May 28, 2026 | Option exercise | +328 | – | – | 66,509 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Stephen Hoge Officer | Oct 15, 2026 | 39,145 | $8.64M | Oct 15, 2026 | Stock Option Exercise |
| Stephen Hoge Officer | Oct 14, 2026 | 39,224 | $8.37M | Oct 14, 2026 | Stock Option Exercise |
| Stephen Hoge Officer | Sep 15, 2026 | 40,281 | $5.88M | Sep 15, 2026 | Stock Option Exercise |
| Stephen Hoge Officer | Sep 14, 2026 | 40,294 | $5.81M | Sep 14, 2026 | Stock Option Exercise |
| James M. Mock Officer | Sep 10, 2026 | 34,836 | $4.69M | Sep 10, 2026 | Restricted Stock Vesting |
| Shannon Thyme Klinger Officer | Sep 1, 2026 | 3,471 | $485.77K | Sep 1, 2026 | Stock Option Exercise |
| Stephane Bancel Officer, Director | Aug 5, 2026 | 499,246 | $28.96M | Aug 5, 2026 | Stock Option Exercise |
| Stephen Hoge Officer | Jul 15, 2026 | 53,336 | $3.61M | Jul 15, 2026 | Stock Option Exercise |
| Paul Sagan Former Director | Jun 18, 2026 | 25,770 | $1.66M | Jun 18, 2026 | Stock Option Exercise |
| Stephen Hoge Officer | Jun 15, 2026 | 53,336 | $2.74M | Jun 15, 2026 | Stock Option Exercise |
| Shannon Thyme Klinger Officer | Jun 4, 2026 | 3,471 | $173.55K | Jun 4, 2026 | Stock Option Exercise |
| Flagship Pioneering, LLC Affiliate | May 21, 2026 | 9,263 | $433.88K | May 21, 2026 | Options Granted - 08/10/2016 |
| Stephen Hoge Officer | May 15, 2026 | 53,336 | $2.58M | May 15, 2026 | Option Granted 08/10/2016 |
| Paul Sagan Former Director | May 8, 2026 | 36,759 | $2.00M | May 8, 2026 | Option Granted - 06/26/2018 |
| Abbas Hussain Director | May 1, 2026 | 5,682 | $264.95K | May 1, 2026 | Restricted Stock Vesting |